SPONSOR
Allist Pharmaceuticals, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: Locally Advanced or Metastatic Non-small Cell Lung CancerNon-small Cell Lung Cancer
Allist Pharmaceuticals, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Locally Advanced or Metastatic Non-small Cell Lung Cancer, Non-small Cell Lung Cancer.
The trial portfolio spans Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Allist Pharmaceuticals, Inc.
How many clinical trials has Allist Pharmaceuticals, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Allist Pharmaceuticals, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Locally Advanced or Metastatic Non-small Cell Lung Cancer, Non-small Cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Allist Pharmaceuticals, Inc. research focus on?
Allist Pharmaceuticals, Inc. clinical trials span Locally Advanced or Metastatic Non-small Cell Lung Cancer, Non-small Cell Lung Cancer. The research pipeline includes Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Allist Pharmaceuticals, Inc. clinical trial?
To participate in a Allist Pharmaceuticals, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Allist Pharmaceuticals, Inc. trials with current recruitment status updated daily.
Clinical Trials by Allist Pharmaceuticals, Inc.
NCT06955988 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT05276726 Phase 1, Phase 2
Recruiting
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Non-small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology